Supplementary Fig S5 from Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers

crossref（2023）

引用 0|浏览5

暂无评分

摘要

Suppl Fig S5 shows effects of KPT9274 and MRTX849 combinations on the proliferation of KRAS4BG12C and KRAS4BG12D MEFs

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Fig S5 from Anticancer Efficacy of KRAS&lt;sup&gt;G12C&lt;/sup&gt; Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of &lt;i&gt;KRAS&lt;/i&gt;&lt;sup&gt;G12C&lt;/sup&gt;-Mutant Pancreatic and Lung Cancers